Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer?

By News Health
4 hours Ago

(MedPage Today) — A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, according to results from the KEYNOTE-A18 trial…

Source link : https://www.medpagetoday.com/meetingcoverage/sgo/114673

Author :

Publish date : 2025-03-15 17:43:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Why Did Doctors Sue HHS?

Income, Education, and CVD; Maternal Death Worldwide

Can Both Sides of the Aisle Rally Around Better Health?

Inside the Government Study Looking at the Health Effects of Ultraprocessed Foods

Arnold Schwarzenegger Shares Tips on Preserving Joint Health, Mobility

Will scrapping NHS England help improve patient safety?